Acquisitions (Details) - USD ($)	1 Months Ended	3 Months Ended
	Nov. 30, 2024	Mar. 31, 2025	Dec. 31, 2024
Business Acquisition [Line Items]
Non-controlling Interest		$ 4,591,500	$ 4,149,000	[1]
GalvanEyes | BioCenturion Joint Venture
Business Acquisition [Line Items]
Ownership interest percentage	50.00%
VOXX
Business Acquisition [Line Items]
Acquisition costs		900,000
GalvanEyes
Business Acquisition [Line Items]
Cash purchase price of acquisition	$ 2,900,000
Earn out provision period	15 years
Total earn out, maximum potential payment	$ 15,000,000
Current value of earn out	$ 1,500,000
Non-controlling Interest		4,600,000	$ 4,100,000
Revenue from business included in statement of income and comprehensive income		900,000
Net loss from business included in statement of income and comprehensive income		$ (1,100,000)

[1] The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.